Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19-Reference-Cited by-同舟云学术

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Published:2020-05 Issue:5 Volume:181 Page:1036-1045.e9
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Blanco-Melo Daniel,Nilsson-Payant Benjamin E.,Liu Wen-Chun,Uhl Skyler,Hoagland Daisy,Møller Rasmus,Jordan Tristan X.,Oishi Kohei,Panis Maryline,Sachs David,Wang Taia T.,Schwartz Robert E.,Lim Jean K.,Albrecht Randy A.,tenOever Benjamin R.

Funder

U.S. Public Health Service

National Institutes of Health

Defense Advanced Research Projects Agency

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. SARS-CoV-2 Vaccines: Status Report;Amanat;Immunity,2020

2. An inability to maintain the ribonucleoprotein genomic structure is responsible for host detection of negative-sense RNA viruses;Blanco-Melo;bioRxiv,2020

3. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice;Channappanavar;Cell Host Microbe,2016

4. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

5. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia;Chu;Clin. Chem.,2020

Cited by 3638 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to prolonged viral pneumonia in immunocompromised patients with COVID-19;CMI Communications;2024-12

2. Harnessing high-throughput OMICS in emerging zoonotic virus preparedness and response activities;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrier;Journal of Virology;2024-09-12

4. Interferon-stimulated genes and their antiviral activity against SARS-CoV-2;mBio;2024-09-11

5. Phytoconstituents as modulator of inflammatory pathways for COVID‐19: A comprehensive review and recommendations;Phytotherapy Research;2024-09-09